Latest news with #SKSTechnologiesGroup
Yahoo
21-05-2025
- Business
- Yahoo
SKS Technologies Group Limited's (ASX:SKS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 29% over the past three months, it is easy to disregard SKS Technologies Group (ASX:SKS). However, stock prices are usually driven by a company's financial performance over the long term, which in this case looks quite promising. In this article, we decided to focus on SKS Technologies Group's ROE. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for SKS Technologies Group is: 61% = AU$11m ÷ AU$17m (Based on the trailing twelve months to December 2024). The 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each A$1 of shareholders' capital it has, the company made A$0.61 in profit. View our latest analysis for SKS Technologies Group Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. Firstly, we acknowledge that SKS Technologies Group has a significantly high ROE. Additionally, the company's ROE is higher compared to the industry average of 20% which is quite remarkable. So, the substantial 55% net income growth seen by SKS Technologies Group over the past five years isn't overly surprising. As a next step, we compared SKS Technologies Group's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 30%. Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. Is SKS fairly valued? This infographic on the company's intrinsic value has everything you need to know. SKS Technologies Group's ' three-year median payout ratio is on the lower side at 13% implying that it is retaining a higher percentage (87%) of its profits. So it seems like the management is reinvesting profits heavily to grow its business and this reflects in its earnings growth number. Besides, SKS Technologies Group has been paying dividends over a period of three years. This shows that the company is committed to sharing profits with its shareholders. Our latest analyst data shows that the future payout ratio of the company is expected to rise to 19% over the next three years. Consequently, the higher expected payout ratio explains the decline in the company's expected ROE (to 40%) over the same period. Overall, we are quite pleased with SKS Technologies Group's performance. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-02-2025
- Business
- Yahoo
Is Now The Time To Look At Buying SKS Technologies Group Limited (ASX:SKS)?
SKS Technologies Group Limited (ASX:SKS), is not the largest company out there, but it saw a significant share price rise of 50% in the past couple of months on the ASX. While good news for shareholders, the company has traded much higher in the past year. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let's examine SKS Technologies Group's valuation and outlook in more detail to determine if there's still a bargain opportunity. Check out our latest analysis for SKS Technologies Group SKS Technologies Group appears to be expensive according to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 35.53x is currently well-above the industry average of 18.36x, meaning that it is trading at a more expensive price relative to its peers. Another thing to keep in mind is that SKS Technologies Group's share price is quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards the levels of its industry peers over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard for it to fall back down into an attractive buying range again. Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. SKS Technologies Group's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value. Are you a shareholder? It seems like the market has well and truly priced in SKS's positive outlook, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe SKS should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed. Are you a potential investor? If you've been keeping an eye on SKS for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for SKS, which means it's worth diving deeper into other factors in order to take advantage of the next price drop. If you want to dive deeper into SKS Technologies Group, you'd also look into what risks it is currently facing. For example - SKS Technologies Group has 1 warning sign we think you should be aware of. If you are no longer interested in SKS Technologies Group, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
04-02-2025
- Business
- Yahoo
Is Now The Time To Look At Buying SKS Technologies Group Limited (ASX:SKS)?
SKS Technologies Group Limited (ASX:SKS), is not the largest company out there, but it saw a significant share price rise of 50% in the past couple of months on the ASX. While good news for shareholders, the company has traded much higher in the past year. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let's examine SKS Technologies Group's valuation and outlook in more detail to determine if there's still a bargain opportunity. Check out our latest analysis for SKS Technologies Group SKS Technologies Group appears to be expensive according to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 35.53x is currently well-above the industry average of 18.36x, meaning that it is trading at a more expensive price relative to its peers. Another thing to keep in mind is that SKS Technologies Group's share price is quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards the levels of its industry peers over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard for it to fall back down into an attractive buying range again. Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. SKS Technologies Group's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value. Are you a shareholder? It seems like the market has well and truly priced in SKS's positive outlook, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe SKS should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed. Are you a potential investor? If you've been keeping an eye on SKS for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for SKS, which means it's worth diving deeper into other factors in order to take advantage of the next price drop. If you want to dive deeper into SKS Technologies Group, you'd also look into what risks it is currently facing. For example - SKS Technologies Group has 1 warning sign we think you should be aware of. If you are no longer interested in SKS Technologies Group, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
31-01-2025
- Business
- Yahoo
ASX Stocks Estimated To Be Trading Below Fair Value In January 2025
The Australian stock market recently saw the ASX200 reach a record high of 8,566 points before closing slightly lower at 8,532 points, buoyed by positive investor sentiment due to easing concerns over potential tariffs on China. In this environment of fluctuating indices and sector performances, identifying undervalued stocks—those trading below their perceived fair value—can offer investors potential opportunities for growth amidst the broader market dynamics. Name Current Price Fair Value (Est) Discount (Est) SKS Technologies Group (ASX:SKS) A$2.09 A$3.83 45.4% Mader Group (ASX:MAD) A$6.20 A$11.91 47.9% Atlas Arteria (ASX:ALX) A$5.07 A$9.51 46.7% MLG Oz (ASX:MLG) A$0.625 A$1.17 46.7% SciDev (ASX:SDV) A$0.47 A$0.87 46.1% Charter Hall Group (ASX:CHC) A$15.72 A$28.70 45.2% IDP Education (ASX:IEL) A$13.34 A$26.40 49.5% ReadyTech Holdings (ASX:RDY) A$3.19 A$6.18 48.4% South32 (ASX:S32) A$3.36 A$6.68 49.7% Integral Diagnostics (ASX:IDX) A$3.12 A$6.17 49.4% Click here to see the full list of 48 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. We'll examine a selection from our screener results. Overview: Aussie Broadband Limited offers telecommunications and technology services in Australia with a market cap of A$1.14 billion. Operations: The company's revenue segments include Business (A$96.97 million), Wholesale (A$159.73 million), Residential (A$585.07 million), Symbio Group (A$69.93 million), and Enterprise and Government (A$88.04 million). Estimated Discount To Fair Value: 38.6% Aussie Broadband appears undervalued, trading at A$3.94 compared to an estimated fair value of A$6.42, indicating it's priced 38.6% below its intrinsic value based on discounted cash flow analysis. Despite significant insider selling recently, earnings are projected to grow significantly at 22.34% annually, outpacing the broader Australian market's growth rate of 12.5%. Recent strategic moves include a share buyback program and leadership transition with Brian Maher assuming the CEO role in March 2025. Upon reviewing our latest growth report, Aussie Broadband's projected financial performance appears quite optimistic. Delve into the full analysis health report here for a deeper understanding of Aussie Broadband. Overview: Integral Diagnostics Limited is a healthcare services company that provides diagnostic imaging services to medical professionals and their patients in Australia and New Zealand, with a market cap of A$1.13 billion. Operations: The company generates revenue of A$469.70 million from its diagnostic imaging facilities operations in Australia and New Zealand. Estimated Discount To Fair Value: 49.4% Integral Diagnostics is trading at A$3.12, significantly below its estimated fair value of A$6.17, suggesting it's undervalued by over 49% based on discounted cash flow analysis. Revenue growth is forecasted at 15.5% annually, surpassing the Australian market average of 6%. However, the firm faces challenges like low return on equity forecasts and recent shareholder dilution. Recent board changes include new non-executive directors and a permanent company secretary appointment. In light of our recent growth report, it seems possible that Integral Diagnostics' financial performance will exceed current levels. Click to explore a detailed breakdown of our findings in Integral Diagnostics' balance sheet health report. Overview: Select Harvests Limited is an Australian company involved in the cultivation, processing, packaging, and sale of almonds and their by-products with a market capitalization of A$652.27 million. Operations: The company generates revenue primarily from its almond segment, amounting to A$337.29 million. Estimated Discount To Fair Value: 30.5% Select Harvests is trading at A$4.64, below its estimated fair value of A$6.68, indicating it's undervalued by over 30% based on cash flow analysis. The company has returned to profitability with annual earnings growth expected at 36.08%, outpacing the Australian market's forecasted growth. Recent executive changes include Liam Nolan as CFO and Mark Rhys Davies as Joint Company Secretary, enhancing financial leadership amidst improving financial performance and revenue growth forecasts of 8.5% annually. Our growth report here indicates Select Harvests may be poised for an improving outlook. Get an in-depth perspective on Select Harvests' balance sheet by reading our health report here. Explore the 48 names from our Undervalued ASX Stocks Based On Cash Flows screener here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ABB ASX:IDX and ASX:SHV. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
30-01-2025
- Business
- Yahoo
3 Prominent Growth Companies With Strong Insider Ownership
As global markets continue to navigate political developments and economic shifts, U.S. stocks have been buoyed by optimism surrounding trade policies and advancements in artificial intelligence, with major indices reaching new highs. In this environment, growth stocks have outpaced their value counterparts, capturing the attention of investors looking for robust opportunities. A key characteristic of a promising stock in such conditions is strong insider ownership, which often signals confidence from those closest to the company's operations and strategy. Name Insider Ownership Earnings Growth Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) 17.3% 20.5% SKS Technologies Group (ASX:SKS) 29.7% 24.8% Laopu Gold (SEHK:6181) 36.4% 36.6% Pharma Mar (BME:PHM) 11.9% 55.1% Kingstone Companies (NasdaqCM:KINS) 20.8% 24.9% Fine M-TecLTD (KOSDAQ:A441270) 17.2% 135% Elliptic Laboratories (OB:ELABS) 26.8% 121.1% Fulin Precision (SZSE:300432) 13.6% 71% HANA Micron (KOSDAQ:A067310) 18.2% 119.4% Findi (ASX:FND) 35.8% 110.7% Click here to see the full list of 1482 stocks from our Fast Growing Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Scandi Standard AB (publ) is engaged in the production and sale of chilled, frozen, and ready-to-eat chicken products across Sweden, Norway, Ireland, Denmark, Finland, Germany, the United Kingdom, rest of Europe and internationally with a market cap of SEK5.45 billion. Operations: The company's revenue is derived from its Ready-To-Cook segment, which generated SEK9.80 billion, and its Ready-To-Eat segment, contributing SEK2.56 billion. Insider Ownership: 14.9% Earnings Growth Forecast: 20.7% p.a. Scandi Standard's earnings are forecast to grow significantly at 20.7% annually, outpacing the Swedish market average. Revenue growth is also expected to surpass the market, albeit at a slower rate of 5.4%. Despite an unstable dividend track record and high debt levels, insider confidence is evident with substantial buying activity and no significant selling in recent months. The stock trades at 51.3% below estimated fair value but shows low future Return on Equity projections. Dive into the specifics of Scandi Standard here with our thorough growth forecast report. Insights from our recent valuation report point to the potential undervaluation of Scandi Standard shares in the market. Simply Wall St Growth Rating: ★★★★★☆ Overview: Suzhou Zelgen Biopharmaceuticals Co., Ltd. operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative drugs, with a market cap of CN¥17.42 billion. Operations: The company's revenue is primarily derived from its pharmaceuticals segment, amounting to CN¥488.45 million. Insider Ownership: 29.4% Earnings Growth Forecast: 127.9% p.a. Suzhou Zelgen Biopharmaceuticals is positioned for substantial growth, with earnings expected to rise 127.93% annually and revenue projected to grow at an impressive 61.5%, outpacing the Chinese market significantly. The company is trading at 56.1% below its estimated fair value, presenting a potential opportunity despite low future Return on Equity forecasts of 16.1%. No recent insider buying or selling activity has been reported over the past three months. Get an in-depth perspective on Suzhou Zelgen BiopharmaceuticalsLtd's performance by reading our analyst estimates report here. Our valuation report unveils the possibility Suzhou Zelgen BiopharmaceuticalsLtd's shares may be trading at a premium. Simply Wall St Growth Rating: ★★★★★☆ Overview: Chongqing Mas Sci.& offers safety technology equipment and safety information services in China, with a market cap of CN¥4.08 billion. Operations: The company generates revenue from its safety technology equipment and safety information services in China. Insider Ownership: 21.8% Earnings Growth Forecast: 29.1% p.a. Chongqing Mas Sci.& is poised for robust growth, with earnings projected to increase by 29.15% annually and revenue expected to rise by 23.7%, both surpassing the Chinese market averages. Despite a low future Return on Equity forecast of 10%, the company's insider ownership remains significant, providing potential alignment with shareholder interests. Recent events include a completed share buyback and discussions on capital structure adjustments at a special shareholders meeting in December 2024. Click here and access our complete growth analysis report to understand the dynamics of Chongqing Mas Sci.& The analysis detailed in our Chongqing Mas Sci.& valuation report hints at an inflated share price compared to its estimated value. Navigate through the entire inventory of 1482 Fast Growing Companies With High Insider Ownership here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OM:SCST SHSE:688266 and SZSE:300275. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
